3-deoxyglucosone and AGEs in uremic complications: Inactivation of glutathione peroxidase by 3-deoxyglucosone

Kidney International, Supplement

Volumn 59, Issue 78, 2001, Pages

  Niwa, T ^a   Tsukushi, S ^a  

^a NAGOYA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Atherosclerosis; Dialysis related amyloidosis; Imidazolone; Oxidative stress; Uremia

Indexed keywords

3 DEOXYGLUCOSONE; ADVANCED GLYCATION END PRODUCT; ALDEHYDE REDUCTASE; AMYLOID; ENZYME INHIBITOR; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; LYSINE DERIVATIVE; 3-DEOXYGLUCOSONE; DEOXYGLUCOSE; DRUG DERIVATIVE; EPIDERMAL GROWTH FACTOR; GLUCOSE; GLUTATHIONE REDUCTASE; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; HEPARIN-BINDING EGF-LIKE GROWTH FACTOR;

AMYLOIDOSIS; AORTA; ATHEROSCLEROSIS; BLOOD LEVEL; CONFERENCE PAPER; CYTOTOXICITY; DETOXIFICATION; DIABETES MELLITUS; ENZYME ACTIVITY; ENZYME INACTIVATION; ERYTHROCYTE LEVEL; GLYCATION; HUMAN; HYPERGLYCEMIA; OXIDATIVE STRESS; PRIORITY JOURNAL; UREMIA; ANIMAL; APOPTOSIS; ARTERIOSCLEROSIS; BIOSYNTHESIS; BLOOD; CELL DIVISION; DRUG ANTAGONISM; DRUG EFFECT; ERYTHROCYTE; METABOLISM; REVIEW;

AMYLOIDOSIS; ANIMALS; APOPTOSIS; ARTERIOSCLEROSIS; CELL DIVISION; DEOXYGLUCOSE; EPIDERMAL GROWTH FACTOR; ERYTHROCYTES; GLUCOSE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLYCOSYLATION END PRODUCTS, ADVANCED; HUMANS; OXIDATIVE STRESS; UREMIA;

EID: 0035122180     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2001.59780037.x     Document Type: Conference Paper

References (33)

1. Imidazolone, a novel advanced glycation end product, is present at high levels in kidneys of rats with streptozotocin-induced diabetes
2. Aging of proteins: Immunological detection of a glucose-derived pyrrole formed during Maillard reaction in vivo
3. Formation of pentosidine during nonenzymatic browning of proteins by glucose
4. ∈-(carboxymethyl) lysine in dialysis-related amyloidosis
5. 2-m with advanced glycation end products as observed in dialysis-related amyloidosis by 3-DG accumulating in uremic serum
6. 2 microglobulin is modified with imidazolone, a novel advanced glycation end product, in dialysis-related amyloidosis
7. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients
8. Mechanisms of browning degradation of D-fructose in special comparison with D-glucose-glycine reaction
9. Identification of fructose-3-phosphate in the lens of diabetic rats
10. Metabolism of fructose- 3-phosphate in the diabetic rat lens
11. 31P NMR spectroscopy
12. Selective induction of heparin-binding epidermal growth factor-like growth factor by methylglyoxal and 3-deoxyglucosone in rat aortic smooth muscle cells
13. Induction of apoptotic cell death by methylglyoxal and 3-deoxyglucosone in macrophage-derived cell lines
14. Overexpression of aldehyde reductase protects PC12 cells from the cytotoxicity of methylglyoxal or 3-deoxyglucosone
15. Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: Synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases
16. Teratogenicity of 3-deoxyglucosone and diabetic embryopathy
17. Suppression of cell-cycle progression during the S phase of rat fibroblasts by 3-deoxyglucosone, a Maillard reaction intermediate
18. Inactivation of glutathione reductase by 4-hydroxynonenal and other endogenous aldehydes
19. Effect of 3-deoxyglucosone on the activities of enzymes responsible for glucose metabolism in mouse liver
20. Presence of 3-deoxyglucosone, a potent protein crosslinking intermediate of Maillard reaction, in diabetic serum
21. Elevated serum levels of 3-deoxyglucosone, a potent prote in-cross-linking intermediate of the Maillard reaction, in uremic patients
22. Metabolism of 3-deoxyfructose, an intermediate compound in the Maillard reaction, administered orally or intravenously to rats
23. Detection of 3-deoxyfructose and 3-deoxyglucosone in human urine and plasma: Evidence for intermediate stages of the Maillard reaction in vivo
24. Monkey 3-deoxyglucosone reductase: Tissue distribution and purification of three multiple forms of the kidney enzyme that are identical with dihydrodiol dehydrogenase, aldehyde reductase, and aldose reductase
25. Determination of advanced glycation end products in serum by fluorescence spectroscopy and competitive ELISA
26. 2-Microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis
27. Immunohistochemical detection of advanced glycation end products in dialysis-related amyloidosis
28. 2-Microglobulin dialysis amyloid and its formation: Role of 3-deoxyglucosone and advanced glycation end products
29. Advanced oxidation protien products as a novel marker of oxidative stress in uremia
30. 2 microglobulin treated with oxygen-derived radicals
31. Increased erythrocyte 3-DG and AGEs in diabetic hemodialysis patients: Role of he polyol pathway
32. Accumulation of alphaoxoaldehydes during oxidative stress: Role in cytotoxicity
33. Gas chromatographic/mass spectrometric analysis of erythrocyte 3-deoxyglucosone in hemodialysis patients